cilengitide has been researched along with adenosine diphosphate in 1 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (adenosine diphosphate) | Trials (adenosine diphosphate) | Recent Studies (post-2010) (adenosine diphosphate) |
---|---|---|---|---|---|
194 | 29 | 133 | 23,989 | 498 | 3,114 |
Protein | Taxonomy | cilengitide (IC50) | adenosine diphosphate (IC50) |
---|---|---|---|
Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | 0.45 | |
Heat shock 70 kDa protein 1A | Homo sapiens (human) | 0.5 | |
Sensor protein kinase WalK | Staphylococcus aureus | 7.189 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harder, S; Klinkhardt, U; Kuczka, K; Meyer dos Santos, S; Nelson, K; Picard-Willems, B | 1 |
1 other study(ies) available for cilengitide and adenosine diphosphate
Article | Year |
---|---|
The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow.
Topics: Adenosine Diphosphate; Blood Platelets; Collagen; Endothelial Cells; Fibrinogen; Humans; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Snake Venoms | 2015 |